Miacalcin (Calcitonin-salmon) for Osteoporosis

Overview
Miacalcin is a prescription drug approved by the Food and Drug Administration (FDA) to treat postmenopausal osteoporosis in women who have been postmenopausal for at least five years. Miacalcin may be indicated in cases where other treatments do not work or cannot be tolerated. Miacalcin is also referred to by its drug name, calcitonin-salmon.

Miacalcin is a synthetic version of a hormone secreted by the thyroid gland. Miacalcin is believed to work by reducing the activity of osteoclasts, the cells that break down bone.

How do I take it?
Miacalcin is administered once daily as a subcutaneous or intramuscular injection. Calcium and Vitamin D supplements must be taken daily while on Miacalcin.

Miacalcin comes as in multi-dose vials.

Side effects
The FDA-approved label for Miacalcin lists common side effects including nausea, rash, itchy earlobes, flushing of the face or hands, injection site reactions, feverish sensations, increased nighttime urination, decreased appetite, swollen feet, abdominal pain, and a salty taste in the mouth.

Rare but serious side effects listed for Miacalcin include increased risk for some types of cancer, hypocalcemia (low calcium), and hypersensitivity reactions.

For more details about this treatment, visit:

Miacalcin - RxList
https://www.rxlist.com/miacalcin-drug.htm